YMAB
Y-mAbs Therapeutics, Inc.
$8.61
AlphaVal Unavailable
AlphaVal: YMAB has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.